The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
IL-21 Enhances and Sustains CD8+ T Cell Responses to Achieve Durable Tumor Immunity: Comparative Evaluation of IL-2, IL-15, and IL-21
Abstract
Cytokines that use the common receptor γ-chain for regulating CD8+ T cell responses to Ag include IL-2, IL-15, and the recently identified IL-21. The ability of these cytokines to regulate antitumor activity in mice has generated considerable interest in understanding their mode of action. In this study we compare the abilities of IL-2, IL-15, and IL-21 to stimulate immunity against tumors in a syngeneic thymoma model. Durable cures were only achieved in IL-21-treated mice. By monitoring both endogenous and adoptively transferred tumor Ag-specific CD8+ T cells, it was determined that IL-21 activities overlap with those of IL-2 and IL-15. Similar to IL-2, IL-21 enhanced Ag activation and clonal expansion. However, unlike IL-2 treatment, which induces activation-induced cell death, IL-21 sustained CD8+ T cell numbers long term as a result of increased survival, an effect often attributed to IL-15. These findings indicate that the mechanisms used by IL-21 to promote CD8+ T cell responses offer unique opportunities for its use in malignant diseases and infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
Albert, M. L., Sauter, B., & Bhardwaj, N. (1998) · Nature · doi:10.1038/32183 · Cited by 2,349
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
Ridge, J. P., Di Rosa, F., & Matzinger, P. (1998) · Nature · doi:10.1038/30989 · Cited by 2,342
Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo
Schluns, K. S., Kieper, W. C., Jameson, S. C., & Lefrançois, L. (2000) · Nature Immunology · doi:10.1038/80868 · Cited by 1,618
Progress in human tumour immunology and immunotherapy
Rosenberg, S. A. (2001) · Nature · doi:10.1038/35077246 · Cited by 1,325
IL-15 Receptor Maintains Lymphoid Homeostasis by Supporting Lymphocyte Homing and Proliferation
Lodolce, J. P., Boone, D. L., Chai, S., Swain, R. E., Dassopoulos, T., Trettin, S., & Ma, A. (1998) · Immunity · doi:10.1016/s1074-7613(00)80664-0 · Cited by 1,299
Parrish-Novak, J., Dillon, S. R., Nelson, A., Hammond, A., Sprecher, C., Gross, J. A., Johnston, J., Madden, K., Xu, W., West, J., et al. (2000) · Nature · doi:10.1038/35040504 · Cited by 1,224
Self-citationIntroduction of soluble protein into the class I pathway of antigen processing and presentation
Moore, M. W., Carbone, F. R., & Bevan, M. J. (1988) · Cell · doi:10.1016/s0092-8674(88)91043-4 · Cited by 1,092
lnterleukin-2 programs mouse αβ T lymphocytes for apoptosis
Lenardo, M. J. (1991) · Nature · doi:10.1038/353858a0 · Cited by 1,012
Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15.
Giri, J. G., Ahdieh, M., Eisenman, J., Shanebeck, K., Grabstein, K., Kumaki, S., Namen, A., Park, L. S., Cosman, D., & Anderson, D. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06576.x · Cited by 981
A Critical Role for IL-21 in Regulating Immunoglobulin Production
Ozaki, K., Spolski, R., Feng, C. G., Qi, C.-F., Cheng, J., Sher, A., Morse, H. C., Liu, C., Schwartzberg, P. L., & Leonard, W. J. (2002) · Science · doi:10.1126/science.1077002 · Cited by 978
IL-7 is critical for homeostatic proliferation and survival of naïve T cells
Tan, J. T., Dudl, E., LeRoy, E., Murray, R., Sprent, J., Weinberg, K. I., & Surh, C. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161126098 · Cited by 965
Cytokine control of memory T-cell development and survival
Schluns, K. S., & Lefrançois, L. (2003) · Nature Reviews Immunology · doi:10.1038/nri1052 · Cited by 882
Tan, J. T., Ernst, B., Kieper, W. C., LeRoy, E., Sprent, J., & Surh, C. D. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020066 · Cited by 786
Lin, J.-X., Migone, T.-S., Tseng, M., Friedmann, M., Weatherbee, J. A., Zhou, L., Yamauchi, A., Bloom, E. T., Mietz, J., John, S., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90141-8 · Cited by 752
Maintaining the norm: T-cell homeostasis
Jameson, S. C. (2002) · Nature Reviews Immunology · doi:10.1038/nri853 · Cited by 599
Mora, L. B., Buettner, R., Seigne, J. D., Diaz, J. I., Ahmad, N., Garcia, R., Bowman, T. L., Falcone, R., Fairclough, R., Cantor, A. B., et al. (2002) · PubMed · Cited by 533
IL-21 Limits NK Cell Responses and Promotes Antigen-Specific T Cell Activation
Kasaian, M. T., Whitters, M. J., Carter, L. L., Lowe, L. D., Jussif, J. M., Deng, B., Johnson, K. A., Witek, J. S., Senices, M., Konz, R. F., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00295-9 · Cited by 481
Waldmann, T. (2001) · Immunity · doi:10.1016/s1074-7613(09)00091-0 · Cited by 434
Sotomayor, E. M., Borrello, I., Tubb, E., Rattis, F.-M., Bien, H., Lu, Z., Fein, S., Schoenberger, S., & Levitsky, H. I. (1999) · Nature Medicine · doi:10.1038/10503 · Cited by 407
Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo
Blattman, J. N., Grayson, J. M., Wherry, E. J., Kaech, S. M., Smith, K. A., & Ahmed, R. (2003) · Nature Medicine · doi:10.1038/nm866 · Cited by 396
IL-21 in Synergy with IL-15 or IL-18 Enhances IFN-γ Production in Human NK and T Cells
Strengell, M., Matikainen, S., Sirén, J., Lehtonen, A., Foster, D., Julkunen, I., & Sareneva, T. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.11.5464 · Cited by 394
Natural killer cell receptor signaling
Lanier, L. L. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(03)00039-6 · Cited by 385
IL-15 Promotes the Survival of Naive and Memory Phenotype CD8+ T Cells
Berard, M., Brandt, K., Paus, S. B., & Tough, D. F. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.5018 · Cited by 343
IL-15 and IL-2: a matter of life and death for T cells in vivo
Li, X. C., Demirci, G., Ferrari-Lacraz, S., Groves, C., Coyle, A., Malek, T. R., & Strom, T. B. (2001) · Nature Medicine · doi:10.1038/83253 · Cited by 312
Shrikant, P., Khoruts, A., & Mescher, M. F. (1999) · Immunity · doi:10.1016/s1074-7613(00)80123-5 · Cited by 283
Self-citationWurster, A. L., Rodgers, V. L., Satoskar, A. R., Whitters, M. J., Young, D. A., Collins, M., & Grusby, M. J. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020620 · Cited by 274
Interleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses
Parrish-Novak, J., Foster, D. C., Holly, R. D., & Clegg, C. H. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.5.856 · Cited by 256
Self-citationIL-21 Up-Regulates the Expression of Genes Associated with Innate Immunity and Th1 Response
Strengell, M., Sareneva, T., Foster, D., Julkunen, I., & Matikainen, S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.3600 · Cited by 250
Interleukin-21 is a growth and survival factor for human myeloma cells
Brenne, A.-T., Baade Ro, T., Waage, A., Sundan, A., Borset, M., & Hjorth-Hansen, H. (2002) · Blood · doi:10.1182/blood.v99.10.3756 · Cited by 168
Ma, H.-L., Whitters, M. J., Konz, R. F., Senices, M., Young, D. A., Grusby, M. J., Collins, M., & Dunussi-Joannopoulos, K. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.608 · Cited by 162
Prlic, M., Lefrancois, L., & Jameson, S. C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020767 · Cited by 158
Schmidt, C. S., & Mescher, M. F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2561 · Cited by 135
Toes, R. E. M., Schoenberger, S. P., van der Voort, E. I. H., Offringa, R., & Melief, C. J. M. (1998) · Seminars in Immunology · doi:10.1006/smim.1998.0147 · Cited by 117
Contrasting Roles of IL-2 and IL-15 in the Life and Death of Lymphocytes
Waldmann, T. A., Dubois, S. P., & Tagaya, Y. (2001) · Immunity · doi:10.1016/s1074-7613(01)00093-0 · Cited by 115
Kishida, T., Asada, H., Itokawa, Y., Cui, F.-D., Shin‐Ya, M., Gojo, S., Yasutomi, K., Ueda, Y., Yamagishi, H., Imanishi, J., et al. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00222-3 · Cited by 112
Helmich, B. K., & Dutton, R. W. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6500 · Cited by 93
CD4+8− help prevents rapid deletion of CD8+ cells after a transient response to antigen
Kirberg, J., And, L. B., & von Boehmer, H. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230835 · Cited by 87
Dai, Z., Arakelov, A., Wagener, M. E., et al. (1999) · PubMed · Cited by 84
Activation-Induced Nonresponsiveness: A Th-Dependent Regulatory Checkpoint in the CTL Response
Tham, E. L., Shrikant, P. A., & Mescher, M. F. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1190 · Cited by 82
Self-citationKedl, R. M., Jordan, M. B., Potter, T. A., Kappler, J. W., Marrack, P., & DOW, S. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191371898 · Cited by 80
Ugai, S., Shimozato, O., Kawamura, K., Wang, Y., Yamaguchi, T., Saisho, H., Sakiyama, S., & Tagawa, M. (2003) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700552 · Cited by 80
Differentiation of human γδ T cells towards distinct memory phenotypes
Eberl, M., Engel, R., Beck, E., & Jomaa, H. (2002) · Cellular Immunology · doi:10.1016/s0008-8749(02)00519-1 · Cited by 75
Opposing Effects of IL-2 in Tumor Immunotherapy: Promoting CD8 T Cell Growth and Inducing Apoptosis
Shrikant, P. A., & Mescher, M. F. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.1753 · Cited by 65
Self-citationNew insights into the role of 4-1BB in immune responses: beyond CD8+ T cells
Kwon, B., Lee, H. W., & Kwon, B. S. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02263-9 · Cited by 63
Multiple γc-dependent cytokines regulate T-cell development
Malek, T. R., Malek, T. R., Porter, B. O., & He, Y.-W. (1999) · Immunology Today · doi:10.1016/s0167-5699(98)01391-7 · Cited by 63
Goldberg, J. E., Shrikant, P. A., & Mescher, M. F. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.228 · Cited by 54
Self-citationOn CD28/CD40 Ligand Costimulation, Common γ-Chain Signals, and the Alloimmune Response
Demirci, G., Gao, W., Zheng, X. X., Malek, T. R., Strom, T. B., & Li, X. C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4382 · Cited by 24
Cited by
Interleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseases
Akdis, M., Burgler, S., Crameri, R., Eiwegger, T., Fujita, H., Gomez, E., Klunker, S., Meyer, N., O’Mahony, L., Palomares, O., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.050 · Cited by 778
Interleukin-21: Basic Biology and Implications for Cancer and Autoimmunity
Spolski, R., & Leonard, W. J. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090316 · Cited by 696
Zander, R., Schauder, D., Xin, G., Nguyen, C., Wu, X., Zajac, A., & Cui, W. (2019) · Immunity · doi:10.1016/j.immuni.2019.10.009 · Cited by 648
Close encounters of different kinds: Dendritic cells and NK cells take centre stage
Degli-Esposti, M. A., & Smyth, M. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1549 · Cited by 554
Interleukin-21: a double-edged sword with therapeutic potential
Spolski, R., & Leonard, W. J. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4296 · Cited by 548
Metadata
- Authors
- Moroz, A., Eppolito, C., Li, Q., Tao, J., Clegg, C. H., & Shrikant, P. A.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-07
- Volume
- 173
- Issue
- 2
- Pages
- 900-909
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2141312960
- Cited by
- 268
- References
- 47
- FWCI
- 6.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.